Evidence map›Paper›PMID 35516594›Full record

ArticleRSC advances2020

A tumor-microenvironment-responsive nanomaterial for cancer chemo-photothermal therapy.

Kaiyu Wang, Zhiyuan Cai, Rong Fan, Qian Yang, Tao Zhu, Zhongying Jiang, Yuqiang Ma

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Research progress of nanomaterial drug delivery in tumor targeted therapy.Frontiers in bioengineering and biotechnology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Kaiyu WangDepartment of Physics, National Laboratory of Solid State Microstructures, Collaborative Innovation Center of Advanced Microstructures, Nanjing University Nanjing China zhuttd@nju.edu.cn myqiang@nju.edu.cn.
Zhiyuan CaiDepartment of Physics, National Laboratory of Solid State Microstructures, Collaborative Innovation Center of Advanced Microstructures, Nanjing University Nanjing China zhuttd@nju.edu.cn myqiang@nju.edu.cn.
Rong FanKey Laboratory of Micro-nano Electric Sensing Technology and Bionic Devices, College of Electronic and Information Engineering, Yili Normal University Yining China jiangzhying@163.com.
Qian YangKey Laboratory of Micro-nano Electric Sensing Technology and Bionic Devices, College of Electronic and Information Engineering, Yili Normal University Yining China jiangzhying@163.com.
Tao ZhuDepartment of Physics, National Laboratory of Solid State Microstructures, Collaborative Innovation Center of Advanced Microstructures, Nanjing University Nanjing China zhuttd@nju.edu.cn myqiang@nju.edu.cn.ORCID https://orcid.org/0000-0002-8988-8143
Zhongying JiangKey Laboratory of Micro-nano Electric Sensing Technology and Bionic Devices, College of Electronic and Information Engineering, Yili Normal University Yining China jiangzhying@163.com.
Yuqiang MaDepartment of Physics, National Laboratory of Solid State Microstructures, Collaborative Innovation Center of Advanced Microstructures, Nanjing University Nanjing China zhuttd@nju.edu.cn myqiang@nju.edu.cn.ORCID https://orcid.org/0000-0002-5433-3199
Advanced Micro Devices (Canada) · CACollaborative Innovation Center of Advanced Microstructures · CNYili Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Taxol (TAX) is a typical anticancer drug that is widely used in clinical treatment of cancer, while gold nanorods (AuNRs) are a kind of well-known material applied for photothermal therapy (PTT). The therapeutic outcome of TAX in chemotherapy is however limited by drug resistance, while AuNRs often show poor accuracy in PTT. To optimize the functions of TAX and AuNRs, we developed a hydrogen peroxide (H

Identifiers

PMID35516594
PMCPMC9054608
OpenAlexW3034437632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.